Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy (Q44701637)

5 December 2017

title

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy (English)

1 reference

5 December 2017

Addison A Taylor

1 reference

5 December 2017

Omar Shoheiber

series ordinal

1 reference

5 December 2017

publication date

1 November 2003

1 reference

5 December 2017

published in

Congestive Heart Failure

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

324-332

1 reference

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Progression, remission, regression of chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

The economic impact of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Hypertension and current issues in compliance and patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Successful blood pressure control in the African American Study of Kidney Disease and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Validity of information on comorbidity derived rom ICD-9-CCM administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Mechanisms and clinical implications of blood pressure variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Relationships between 24 h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Implications of a health lifestyle and medication analysis for improving hypertension control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

The assessment of refill compliance using pharmacy records: methods, validity, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.03269.X

10.1111/J.1527-5299.2003.03269.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference